The new FLiRT COVID-19 strain is wreaking havoc across Southern states, experiencing some of the highest infection rates in the country.
Savara, based in Pennsylvania, expects to file a marketing application for the therapy in the first half of 2025 and said it plans to present full...
As temperatures rise and the academic year concludes, there's a noticeable increase in travel activities, accompanied by lingering concerns over COVID-19.
FDA has recently categorized three beverage products from Charles Boggini Company, which were recalled due to the presence of undisclosed ingredients.
A novel hormone gel shows promise as a fast-acting, effective male birth control method amid growing interest and ongoing research.
Epilepsy treatments during pregnancy do not impact children's creativity but may affect their executive functions at higher doses
Early introduction of peanuts significantly reduces peanut allergy risk in children, highlighting the importance of following established guidelines for lasting protection against allergies
Mental health challenges are facing by LGBTQ individuals amid awareness efforts, highlighting the need for accessible resources and supportive networks
Study suggests extending HPV testing intervals post-negative tests for cervical cancer prevention, prompting global screening guideline reassessment and healthcare system readiness consideration